Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen Inks Japanese Distribution Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that it has signed up Takeda Rika Kogyo to distribute its genome analysis platform to life sciences research customers in Japan.

The exclusive agreement gives Takeda rights to sell the SmartChip System, which WaferGen is currently commercializing along with its SmartChip Gene Expression Profiling Services through an early-access program.

The SmartChip System includes a 5,184-assay SmartChip, the SmartChip Cycler, and the SmartChip Nanodispenser or Multi-Sample Nanodispenser for studying candidate genes and microRNA panels for disease research.

WaferGen's gene expression profiling services are provided to universities, research hospitals, and drug and biotech companies from the firm's Fremont, Calif. headquarters.

"By improving biomarker identification and validation, we believe that the SmartChip System will make a significant difference by enabling scientists to more quickly and effectively understand disease at the molecular level in order to target therapies," Takeda Rika Kogyo President Takuto Takeda said in a statement.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.